RHY 1.00% 9.9¢ rhythm biosciences limited

News: RHY Rhythm Biosciences Files With TGA To List Colostat On Register Of Therapeutic Goods, page-2

  1. 562 Posts.
    lightbulb Created with Sketch. 86
    "the Team continues to diligently execute on our plans as we target ColoSTAT revenues in late CY22"

    Reading between the lines as revenues are targeted within ~ 6 months a deal, or deals, mustn't be too far off imho
 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.